Literature DB >> 30878306

Weight gain in Major Depressive Disorder: Linking appetite and disordered eating to leptin and ghrelin.

Jessica G Mills1, Theresa A Larkin2, Chao Deng3, Susan J Thomas2.   

Abstract

Major Depressive Disorder (MDD) involves changes in appetite and weight, with a subset of individuals at an increased risk of weight gain. Pathways to weight gain may include appetite disturbances, excess eating, and dysregulation of appetite hormones. However, little research has simultaneously examined relationships between hormones, eating behaviours and MDD symptoms. Plasma ghrelin and leptin, biometrics, eating behaviours and psychopathology were compared between depressed (n = 60) and control (n = 60) participants. Depressed participants were subcategorised into those with increased or decreased appetite/weight for comparison by subtype. The Dutch Eating Behaviours Questionnaire and Yale Food Addiction Scale measured eating behaviours. Disordered eating was higher in MDD than controls, in females than males, and in depressed individuals with increased, compared to decreased, appetite/weight. Leptin levels were higher in females only. Leptin levels correlated positively, and ghrelin negatively, with disordered eating. The results provide further evidence for high levels of disordered eating in MDD, particularly in females. The correlations suggest that excessive eating in MDD is significantly linked to appetite hormones, indicating that it involves physiological, rather than purely psychological, factors. Further, longitudinal, research is needed to better understand whether hormonal factors play a causal role in excessive eating in MDD.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Depression; Emotional eating; Food addiction; Ghrelin; Leptin; Obesity

Mesh:

Substances:

Year:  2019        PMID: 30878306     DOI: 10.1016/j.psychres.2019.03.017

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

Review 1.  Food addiction and psychiatric comorbidities: a review of current evidence.

Authors:  Armando Piccinni; Rachele Bucchi; Claudia Fini; Federica Vanelli; Mauro Mauri; Tiziana Stallone; Ernesto Daniel Cavallo; Cargioli Claudio
Journal:  Eat Weight Disord       Date:  2020-09-23       Impact factor: 4.652

2.  Effects of a Novel Magnesium Complex on Metabolic and Cognitive Functions and the Expression of Synapse-Associated Proteins in Rats Fed a High-Fat Diet.

Authors:  Cemal Orhan; Mehmet Tuzcu; Patrick Brice Deeh Defo; Nurhan Sahin; Sara Perez Ojalvo; Sarah Sylla; James R Komorowski; Kazim Sahin
Journal:  Biol Trace Elem Res       Date:  2021-02-16       Impact factor: 3.738

3.  Cortisol in relation to problematic eating behaviours, adiposity and symptom profiles in Major Depressive Disorder.

Authors:  Jessica G Mills; Theresa A Larkin; Chao Deng; Susan J Thomas
Journal:  Compr Psychoneuroendocrinol       Date:  2021-06-17

Review 4.  The Clinical Obesity Maintenance Model: A Theoretical Framework for Bariatric Psychology.

Authors:  Jayanthi Raman; Dean Spirou; Lisbeth Jahren; Trine Tetlie Eik-Nes
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-14       Impact factor: 5.555

5.  The Ghrelin/Growth Hormone Secretagogue Receptor System Is Involved in the Rapid and Sustained Antidepressant-Like Effect of Paeoniflorin.

Authors:  Yuan Zhang; Min-Zhen Zhu; Xi-He Qin; Yuan-Ning Zeng; Xin-Hong Zhu
Journal:  Front Neurosci       Date:  2021-02-16       Impact factor: 4.677

6.  Preliminary evidence of acylated ghrelin association with depression severity in postmenopausal women.

Authors:  Maria Fernanda Naufel; Amanda Paula Pedroso; Lila Missae Oyama; Mônica Marques Telles; Helena Hachul; Eliane Beraldi Ribeiro
Journal:  Sci Rep       Date:  2021-03-05       Impact factor: 4.379

7.  Reduction of impulsivity in patients receiving deep transcranial magnetic stimulation treatment for obesity.

Authors:  Livio Luzi; Sara Gandini; Stefano Massarini; Federica Bellerba; Ileana Terruzzi; Pamela Senesi; Concetta Macrì; Anna Ferrulli
Journal:  Endocrine       Date:  2021-06-25       Impact factor: 3.633

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.